Dark
Streaming/Mobile
Old Site
Home
Products
Help
Contact Us
Your Account
System Status
Sign-up for a FREE 30-day Stockwatch subscription and SEE NO ADS
02:40:39 EDT Sat 27 Apr 2024
Quotes
Streaming/Mobile
Quick Quotes (x20)
Symbol Search
Company Search
Market Depth
US Options
Montreal Options
Foreign Exchange
Download Close Prices
Short History
Quotes Help
Charts
12 Month Chart
Advanced Chart
Live Intraday Chart
Live Historical Chart
Live Java Intraday Chart
Live Java Historical Chart
Charts Help
News
News Search
SEDAR Search
SEDAR Alerts
News Help
Indexes
Major Indexes
US incl Dow Jones
NASDAQ
S&P CME
PBOT - Phil Ex
TSX - Toronto
TSX-V - TSX Venture
Indexes Help
Portfolio
View Portfolio
Portfolio 1
Portfolio 2
Portfolio 3
Portfolio 4
Portfolio 5
Portfolio 6
Portfolio 7
Portfolio 8
Portfolio 9
Portfolio 10
Value Portfolio
All Portfolios
Portfolio 1
Portfolio 2
Portfolio 3
Portfolio 4
Portfolio 5
Portfolio 6
Portfolio 7
Portfolio 8
Portfolio 9
Portfolio 10
Edit Portfolio
Portfolio 1
Portfolio 2
Portfolio 3
Portfolio 4
Portfolio 5
Portfolio 6
Portfolio 7
Portfolio 8
Portfolio 9
Portfolio 10
Chart Portfolio
Portfolio 1
Portfolio 2
Portfolio 3
Portfolio 4
Portfolio 5
Portfolio 6
Portfolio 7
Portfolio 8
Portfolio 9
Portfolio 10
Live Portfolio
Portfolio 1
Portfolio 2
Portfolio 3
Portfolio 4
Portfolio 5
Portfolio 6
Portfolio 7
Portfolio 8
Portfolio 9
Portfolio 10
View Portfolio News
Daily Summary
Portfolio Help
Analytics
Exchange Statistics
Most Active
Live Most Active
Block Trades
Broker Trades
Halted Stocks
Dividends
Participants
Companies
Trade Workstation
Company Picker
Short Positions
Broker Codes
Analytics Help
Mutual Funds
Mutual Fund Search
Targeted Holder Search
SEDAR Fund Search
Mutual Fund Help
Enter Symbol
or Name
USA
CA
Quote
Chart
News
Closes
Depth
Forgot password?
Trouble logging in?
Login to Stockwatch
Q:SNY
- SANOFI SPON ADR ECH REP 0.5 ORD SHS -
http://www.sanofi-aventis.com
02:40:39 EDT
Sym-X
Bid - Ask
Last
Chg
%Ch
Vol
$Vol
#Tr
Open-Hi-Lo
Year Hi-Lo
Last Tr
News
Delay
SNY
- Q
0.1
43.90
·
49.50
0.5
49.13
-0.23
-0.5
4,148.2
201,436
20,406
48.84
49.47
48.17
56.26 42.63
19:12:39
Jan 25
15 min
RT 2¢
Trade times are ET. News times are ET. Bid/ask/vol sizes in thousands.
Nasdaq Indicators -- Market:
Nasdaq
-- Bid Tick:
Down
-- UPC Restricted:
No
Fundamentals
·
Holders
·
Trade Workstation
·
Market Depth
·
3 Month Closes
·
Technical Charts
1 yr
|
2 yr
|
3 yr
|
5 yr
|
10 yr
|
15 yr
|
20 yr
·
Live Charts
1 yr
|
1 day
·
1yr Bulletins
·
Historical
·
Options
·
Portfolio
Recent Trades - Last 10 of 20406
More trades...
Time ET
Ex
Price
Change
Volume
19:12:39
Q
49.10
-0.26
96
18:17:03
Q
49.12
-0.24
2
18:17:03
Q
49.13
-0.23
5
16:00:04
Q
49.13
-0.23
2,616
16:00:04
Q
49.13
-0.23
200
16:00:01
Q
49.13
-0.23
626
16:00:01
Q
49.13
-0.23
188
16:00:01
Q
49.13
-0.23
79
16:00:01
Q
49.13
-0.23
4
16:00:01
Q
49.13
-0.23
108
Sign-up for a FREE 30-day Stockwatch subscription and SEE NO ADS
Recent Bulletins
News Releases
In The News
Other
Date ET
Symbol
Type
Headline
2024-01-25 14:29
U:SNY
News Release
200
Dupixent ‚ ® (dupilumab) FDA Approved as First and Only Treatment Indicated for Children Aged 1 Year and Older with Eosinophilic Esophagitis (EoE)
2024-01-23 01:00
U:SNY
News Release
200
Inhibrx Announces Sale of INBRX-101 to Sanofi for an aggregate value of up to $2.2B
2023-11-30 08:30
U:SNY
News Release
200
Teva Completes Closing of Exclusive Collaboration Deal to Deliver Inflammatory Bowel Disease Treatment
2023-11-27 01:30
U:SNY
News Release
200
Dupixent ‚ ® (dupilumab) Significantly Reduced COPD Exacerbations in Second Positive Phase 3 Trial, Accelerating FDA Submission and Confirming Potential to Become First Approved Biologic for This Serious Disease
2023-11-02 12:15
U:SNY
News Release
200
Sanofi honors 10 advocacy organizations promoting health equity solutions in underserved U.S. communities
2023-11-01 07:00
U:SNY
News Release
200
Sanofi launches "The 1 Pledge" movement to drive early screening for type 1 diabetes in the U.S.
2023-10-22 14:59
U:SNY
News Release
200
Dupixent ‚ ® (dupilumab) Phase 3 Results Show Sustained Efficacy for Up to One Year in Children 1 to 11 Years of Age with Eosinophilic Esophagitis (EoE)
2023-10-17 09:00
U:SNY
News Release
200
Sanofi Bridging the Gap between the Homeless and Society via Futsal
2023-10-10 08:00
U:SNY
News Release
200
Stagwell's (STGW) The Harris Poll Unveils First-of-its-kind Global Hemophilia Survey on the Daily Challenges for Patients, Caregivers, and Providers
2023-10-04 01:07
U:SNY
News Release
200
Sanofi and Teva Announce Exclusive Collaboration to Deliver Inflammatory Bowel Disease Treatment
2023-09-26 01:29
U:SNY
News Release
200
Dupixent ‚ ® (dupilumab) sBLA for Treatment of Eosinophilic Esophagitis (EoE) in Children Aged 1 to 11 Accepted for FDA Priority Review
2023-09-14 06:00
U:SNY
News Release
200
First Wave BioPharma Announces Exclusive Global License Agreement for Capeserod from Sanofi
2023-09-13 08:15
U:SNY
News Release
200
Sanofi and rapper/actor Ice-T unveil trailer for The Season as a warning against the flu
2023-07-25 08:00
U:SNY
News Release
200
Sanofi Consumer Healthcare North America Earns B Corp Certification in Recognition of Environmental, Social Impact
2023-07-20 08:00
U:SNY
News Release
200
Recludix Pharma Enters into a Strategic Collaboration with Sanofi to Advance Novel Oral STAT6 Inhibitor in Multiple Immunological and Inflammatory Indications
2023-05-18 11:55
U:SNY
News Release
200
Sanofi Applauds Supreme Court Ruling Supporting Scientific Innovation by Striking Down Amgen's Asserted PCSK9 Patent Claims in Amgen v Sanofi